Diagnosis of invasive fungal diseases in pediatric patients

Zoi-Dorothea Pana1, Katerina Vikelouda1, Emmanuel Roilides1

  • 1a Infectious Diseases Unit, 3rd Department of Paediatrics, Faculty of Medicine , Aristotle University School of Health Sciences , Thessaloniki , Greece.

Abstract

Insights

Accurate diagnosis of invasive fungal infections (IFIs) in children is crucial for effective antifungal treatment. New non-invasive diagnostic methods show promise but require further validation in pediatric populations.

Area of Science:

  • Pediatric Infectious Diseases
  • Mycology
  • Diagnostic Microbiology

Background:

  • Optimal management of invasive fungal infections (IFIs) in children necessitates precise and timely diagnosis.
  • Traditional diagnostic methods (culture, microscopy, histopathology) have limitations in sensitivity and specificity.
  • Development of alternative non-invasive diagnostic methods is driven by the need for improved IFI detection.

Purpose of the Study:

  • To review current perspectives on IFI diagnosis in children.
  • To highlight interpretation challenges and the need for further pediatric evaluation of diagnostic tools.
  • To emphasize the role of new diagnostic technologies in conjunction with traditional methods.

Main Methods:

  • Review of traditional diagnostic approaches including culture, microscopy, and histopathology.
  • Discussion of emerging non-invasive diagnostic methods detecting fungal components (antigens, nucleic acids).
  • Focus on galactomannan, 1,3 β-D-glucan assays, and novel technologies like T2Candida in pediatric contexts.

Main Results:

  • Traditional methods are gold standards but often lack sufficient sensitivity and specificity.
  • Non-culture methods like galactomannan and 1,3 β-D-glucan assays are efficient for diagnosis and monitoring.
  • New technologies, such as T2Candida, are emerging but not yet standardized or validated in children.

Conclusions:

  • New diagnostic tools hold potential to enhance diagnostic capacity for IFIs in children.
  • Integration of novel methods with traditional approaches is key for improved pediatric IFI management.
  • Further validation and standardization of new diagnostic technologies in pediatric populations are essential.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
349
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
676
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
609